| |
Cancer
|
Not Cancer
|
|---|
| |
N
|
%
|
N
|
%
|
|---|
|
Cancer status
| | | | |
|
Cancer Tissue
|
68
|
100
|
0
|
0
|
|
Not Cancer Breast Tissue
|
0
|
0
|
89
|
87
|
|
Other Tissue
|
0
|
0
|
13
|
13
|
|
Total (N)
|
68
| |
102
| |
|
Gender
| | | | |
|
Male
|
4
|
7
|
6
|
8
|
|
Female
|
54
|
93
|
70
|
92
|
|
Total (N)
|
58
| |
76
| |
|
Age at diagnosis
| | | | |
|
<40 years
|
16
|
30
|
42
|
74
|
|
40-49 years
|
11
|
21
|
10
|
18
|
|
≥50 years
|
26
|
49
|
5
|
9
|
|
Total (N)
|
53
| |
57
| |
|
HER2 status
| | | | |
|
Positive
|
7
|
14
| | |
|
Negative
|
42
|
86
| | |
|
Total (N)
|
49
| | | |
|
Estrogen receptor status
| | | | |
|
Positive
|
29
|
59
| | |
|
Negative
|
20
|
41
| | |
|
Total (N)
|
49
| | | |
|
Progesterone receptor status
| | | | |
|
Positive
|
19
|
40
| | |
|
Negative
|
29
|
60
| | |
|
Total (N)
|
48
| | | |
|
Triple negative (ER-, PR-, HER2-)
|
16
|
33
| | |
|
Total (N)
|
48
| | | |
|
Status
| | | | |
|
Died
|
11
|
69
| | |
|
Alive
|
5
|
31
| | |
|
Total (N)
|
16
| | | |
|
Tribe
| | | | |
|
Luyha
|
11
|
38
| | |
|
Kalenjin
|
10
|
34
| | |
|
Kikuyu
|
4
|
14
| | |
|
Luo
|
3
|
10
| | |
|
Teso
|
1
|
3
| | |
|
Total (N)
|
29
| | | |
|
Hormone-based Contraception
| | | | |
|
Single agent (Injected or Pill)
|
11
|
50
| | |
|
Combined (Injected and Pill)
|
2
|
9
| | |
|
Neither
|
9
|
41
| | |
|
Total (N)
|
22
| | | |
|
Marriage
| | | | |
|
Married or widowed
|
24
|
92
| | |
|
Not Married
|
2
|
8
| | |
|
Total (N)
|
26
| | | |
|
Median age (years)
|
48.5 years (N = 38)
|
31 years old (N = 9)
|
|
Mean age (years)
|
51.9 years (N = 38)
|
35.6 years (N = 9)
|
